AMPHENOL CORPORATION (APH) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.54%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.54% | Share-based compensation / revenue. Period ending 2026-06-30. $157.10M ÷ $29.01B × 100 ≈ 0.54% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 29.01B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 157.10M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 7.84B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $29.01B | $157.10M | $7.84B | (m) | (m) | 0.54% | (m) | (m) |
| 2026-03-31 | (m) | $25.90B | $143.00M | $6.68B | (m) | (m) | 0.55% | (m) | (m) |
| 2025-12-31 | $647.00M | $23.09B | $135.40M | $5.87B | (m) | 2.80% | 0.59% | (m) | (m) |
| 2025-09-30 | (m) | $20.97B | $124.40M | $5.10B | (m) | (m) | 0.59% | (m) | (m) |
| 2025-06-30 | (m) | $18.82B | $117.00M | $4.22B | (m) | (m) | 0.62% | (m) | (m) |
| 2025-03-31 | (m) | $16.78B | $112.30M | $3.50B | (m) | (m) | 0.67% | (m) | (m) |
| 2024-12-31 | $453.00M | $15.22B | $109.50M | $3.16B | (m) | 2.98% | 0.72% | (m) | (m) |
| 2024-09-30 | (m) | $14.23B | $106.50M | $2.89B | (m) | (m) | 0.75% | (m) | (m) |
| 2024-06-30 | (m) | $13.39B | $103.90M | $2.73B | (m) | (m) | 0.78% | (m) | (m) |
| 2024-03-31 | (m) | $12.84B | $101.10M | $2.65B | $141.70M | (m) | 0.79% | 18.72× | Reported |
| 2023-12-31 | $342.20M | $12.55B | $99.00M | $2.56B | $139.50M | 2.73% | 0.79% | 18.35× | Reported |
| 2023-09-30 | (m) | $12.47B | $97.70M | $2.54B | $141.60M | (m) | 0.78% | 17.91× | Reported |
| 2023-06-30 | (m) | $12.56B | $94.40M | $2.56B | $140.80M | (m) | 0.75% | 18.17× | Reported |
| 2023-03-31 | (m) | $12.65B | $91.50M | $2.59B | $136.20M | (m) | 0.72% | 19.00× | Reported |
| 2022-12-31 | $323.60M | $12.62B | $89.50M | $2.59B | $128.40M | 2.56% | 0.71% | 20.14× | Reported |
| 2022-09-30 | (m) | $12.41B | $87.00M | $2.51B | $120.10M | (m) | 0.70% | 20.92× | Reported |
| 2022-06-30 | (m) | $11.93B | $84.60M | $2.40B | $116.40M | (m) | 0.71% | 20.64× | Reported |
| 2022-03-31 | (m) | $11.45B | $83.60M | $2.23B | $115.00M | (m) | 0.73% | 19.39× | Reported |
| 2021-12-31 | $317.70M | $10.88B | $83.00M | $2.11B | $115.50M | 2.92% | 0.76% | 18.23× | Reported |
| 2021-09-30 | (m) | $10.28B | $79.70M | $2.00B | $115.00M | (m) | 0.78% | 17.40× | Reported |
| 2021-06-30 | (m) | $9.78B | $77.50M | $1.91B | $114.10M | (m) | 0.79% | 16.70× | Reported |
| 2021-03-31 | (m) | $9.11B | $74.20M | $1.79B | $115.20M | (m) | 0.81% | 15.51× | Reported |
| 2020-12-31 | $260.70M | $8.60B | $70.50M | $1.64B | $115.40M | 3.03% | 0.82% | 14.20× | Reported |
| 2020-09-30 | (m) | $8.32B | $67.60M | $1.58B | $115.20M | (m) | 0.81% | 13.71× | Reported |
| 2020-06-30 | (m) | $8.10B | $65.20M | $1.52B | $116.90M | (m) | 0.80% | 12.98× | Reported |
| 2020-03-31 | (m) | $8.13B | $64.00M | $1.56B | $116.70M | (m) | 0.79% | 13.37× | Reported |
| 2019-12-31 | $234.20M | $8.23B | $63.00M | $1.62B | $117.60M | 2.85% | 0.77% | 13.77× | Reported |
| 2019-09-30 | (m) | $8.30B | $61.60M | $1.65B | $115.90M | (m) | 0.74% | 14.21× | Reported |
| 2019-06-30 | (m) | $8.33B | $59.40M | $1.68B | $110.90M | (m) | 0.71% | 15.13× | Reported |
| 2019-03-31 | (m) | $8.29B | $57.30M | $1.69B | $106.90M | (m) | 0.69% | 15.77× | Reported |
| 2018-12-31 | $220.90M | $8.20B | $55.60M | $1.69B | $101.70M | 2.69% | 0.68% | 16.59× | Reported |
| 2018-09-30 | (m) | (m) | $53.00M | $1.63B | $100.30M | (m) | (m) | 16.24× | Reported |
| 2018-06-30 | (m) | (m) | $51.30M | $1.56B | $100.10M | (m) | (m) | 15.61× | Reported |
| 2018-03-31 | (m) | (m) | $50.30M | $1.49B | $97.50M | (m) | (m) | 15.29× | Reported |
| 2017-12-31 | $193.70M | (m) | $49.70M | $1.43B | $92.30M | (m) | (m) | 15.47× | Reported |
| 2017-09-30 | (m) | (m) | $49.20M | $1.37B | $85.70M | (m) | (m) | 15.95× | Reported |
| 2017-06-30 | (m) | (m) | $48.80M | $1.32B | $79.20M | (m) | (m) | 16.61× | Reported |
| 2017-03-31 | (m) | (m) | $48.10M | $1.28B | $73.80M | (m) | (m) | 17.34× | Reported |
| 2016-12-31 | $166.10M | (m) | $47.60M | $1.21B | $72.60M | (m) | (m) | 16.60× | Reported |
| 2016-09-30 | (m) | (m) | $47.60M | $1.16B | $71.40M | (m) | (m) | 16.18× | Reported |
| 2016-06-30 | (m) | (m) | $47.20M | $1.12B | $70.30M | (m) | (m) | 15.98× | Reported |
| 2016-03-31 | (m) | (m) | $45.70M | $1.08B | $69.40M | (m) | (m) | 15.62× | Reported |
| 2015-12-31 | $124.70M | (m) | $44.20M | $1.10B | $68.30M | (m) | (m) | 16.17× | Reported |
| 2015-09-30 | (m) | (m) | $44.10M | $1.09B | $71.30M | (m) | (m) | 15.35× | Reported |
| 2015-06-30 | (m) | (m) | $42.40M | $1.07B | $75.30M | (m) | (m) | 14.18× | Reported |
| 2015-03-31 | (m) | (m) | $42.20M | $1.06B | $78.30M | (m) | (m) | 13.57× | Reported |
| 2014-12-31 | $114.80M | (m) | $41.40M | $1.03B | $80.40M | (m) | (m) | 12.87× | Reported |
| 2014-09-30 | (m) | (m) | $38.87M | $997.13M | $76.67M | (m) | (m) | 13.01× | Reported |
| 2014-06-30 | (m) | (m) | $38.14M | $953.79M | $71.63M | (m) | (m) | 13.32× | Reported |
| 2014-03-31 | (m) | (m) | $37.06M | $921.99M | $67.17M | (m) | (m) | 13.73× | Reported |
| 2013-12-31 | $103.42M | (m) | $36.07M | $896.81M | $63.55M | (m) | (m) | 14.11× | Reported |
| 2013-09-30 | (m) | (m) | $34.83M | $876.67M | $62.73M | (m) | (m) | 13.98× | Reported |
| 2013-06-30 | (m) | (m) | $33.49M | $867.86M | $61.84M | (m) | (m) | 14.03× | Reported |
| 2013-03-31 | (m) | (m) | $32.20M | $850.02M | $61.32M | (m) | (m) | 13.86× | Reported |
| 2012-12-31 | $92.48M | (m) | $31.41M | $828.35M | $59.61M | (m) | (m) | 13.90× | Reported |
| 2012-09-30 | (m) | (m) | $30.84M | $771.78M | $55.16M | (m) | (m) | 13.99× | Reported |
| 2012-06-30 | (m) | (m) | $30.40M | $742.17M | $50.49M | (m) | (m) | 14.70× | Reported |
| 2012-03-31 | (m) | (m) | $29.85M | $750.87M | $46.76M | (m) | (m) | 16.06× | Reported |
| 2011-12-31 | $88.88M | (m) | $28.68M | $751.68M | $43.03M | (m) | (m) | 17.47× | Reported |
| 2011-09-30 | (m) | (m) | $27.82M | $777.57M | $42.08M | (m) | (m) | 18.48× | Reported |
| 2011-06-30 | (m) | (m) | $27.15M | $780.65M | $42.15M | (m) | (m) | 18.52× | Reported |
| 2011-03-31 | (m) | (m) | $26.26M | $741.40M | $40.74M | (m) | (m) | 18.20× | Reported |
| 2010-12-31 | $77.57M | (m) | $25.39M | $700.36M | $40.74M | (m) | (m) | 17.19× | Reported |
| 2010-09-30 | (m) | (m) | $23.56M | $648.26M | $40.05M | (m) | (m) | 16.19× | Reported |
| 2010-06-30 | (m) | (m) | $21.83M | $583.42M | $38.44M | (m) | (m) | 15.18× | Reported |
| 2010-03-31 | (m) | (m) | $20.90M | $523.27M | $37.60M | (m) | (m) | 13.92× | Reported |
| 2009-12-31 | (m) | (m) | $20.24M | $488.91M | $36.59M | (m) | (m) | 13.36× | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $16.32M | $632.24M | $39.63M | (m) | (m) | 15.95× | Reported |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $12.44M | $552.86M | $36.88M | (m) | (m) | 14.99× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| METHODE ELECTRONICS INC (MEI) | United States | $0.519B | -13.50 |
| R F INDUSTRIES LTD (RFIL) | United States | $0.090B | 54.79 |